3:29 PM
 | 
Mar 12, 2019
 |  BC Extra  |  Company News

Management tracks: Inovio, Sangamo, Innate

Inovio CMO Mark Bagarazzi has left the company. Inovio Pharmaceuticals Inc. (NASDAQ:INO) said a newly formed medical council -- VPs of Clinical Development Prakash Bhuyan, Jeffrey Skolnik and Scott White -- will now oversee the cancer and infectious disease company's clinical activities.

The company also hired Jacqueline Shea as EVP and COO, succeeding Niranjan Sardesai. Sardesai is now CEO of Geneos Therapeutics Inc. (Plymouth Meeting, Pa.), an Inovio spinout that he co-founded last month to develop personalized cancer treatments. Upon its formation, Geneos raised the first close of...

Read the full 418 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >